Serum magnesium and calcium in preeclampsia: A comparative study at the Korle-Bu Teaching Hospital, Ghana

listen audio

Study Justification:
– Hypertensive disorders in pregnancy contribute to a significant percentage of maternal mortality, especially in developing countries.
– The etiology and pathophysiology of preeclampsia, a common hypertensive disorder, are not well understood.
– Magnesium and calcium are known to play a role in vascular smooth muscle function and may be involved in the development of preeclampsia.
– This study aimed to compare serum magnesium and total calcium levels in preeclamptic and normal pregnant women to determine if there are any differences.
Study Highlights:
– The study was conducted at the Korle-Bu Teaching Hospital in Ghana, which is the largest tertiary referral hospital in the country.
– A comparative cross-sectional study design was used, involving 30 normal pregnant women and 30 preeclamptic women with gestations over 30 weeks and aged between 18 and 35 years.
– Serum magnesium and total calcium levels were measured using a flame atomic absorption spectrometer.
– The results showed no statistically significant difference in serum magnesium and total calcium levels between preeclamptic and normal pregnant women.
Recommendations for Lay Reader:
– The study aimed to compare magnesium and calcium levels in preeclamptic and normal pregnant women.
– The results suggest that there may not be a difference in these levels between the two groups.
– Further research is needed to better understand the role of magnesium and calcium in preeclampsia.
Recommendations for Policy Maker:
– The study findings indicate that serum magnesium and total calcium levels may not differ significantly in preeclamptic women compared to normal pregnant women in Ghana.
– Policy makers should consider the need for additional research to explore other potential factors contributing to the development of preeclampsia.
– Resources should be allocated to support further investigations into the etiology and pathophysiology of preeclampsia.
Key Role Players:
– Researchers and scientists specializing in obstetrics and gynecology
– Medical professionals and clinicians involved in the care of pregnant women
– Policy makers and government officials responsible for healthcare planning and funding
Cost Items for Planning Recommendations:
– Research funding for additional studies on preeclampsia and its potential causes
– Equipment and supplies for laboratory analysis, such as atomic absorption spectrometers
– Training and education for healthcare professionals involved in preeclampsia management and research
– Data management and analysis software
– Support for collaboration and knowledge sharing among researchers and healthcare professionals

The strength of evidence for this abstract is 6 out of 10.
The evidence in the abstract is moderately strong, but there are some areas for improvement. The study design is a comparative cross-sectional study, which provides some evidence for a relationship between serum magnesium and calcium levels in preeclamptic and normal pregnant women. However, the sample size is relatively small with only 30 participants in each group, which may limit the generalizability of the findings. Additionally, the p-values for the comparison of serum magnesium and calcium levels between the two groups are 0.092 and 0.972, respectively, indicating that the differences are not statistically significant. To improve the strength of the evidence, a larger sample size could be used to increase the power of the study. Additionally, conducting a longitudinal study to assess changes in serum magnesium and calcium levels over time in preeclamptic and normal pregnant women could provide more robust evidence.

Background: A large percentage (16% of maternal mortality in developed countries, compared to 9% in developing countries), is due to hypertensive disorders in pregnancy. The etiology of preeclampsia remains unknown, with poorly understood pathophysiology. Magnesium and calcium play an important role in vascular smooth muscle function and therefore a possible role in the development of preeclampsia. Aim: We aimed to compare serum magnesium and total calcium levels of preeclamptic and normal pregnant women at the Korle-Bu Teaching Hospital in Ghana. Patients and methods: A comparative cross-sectional study involving 30 normal pregnant and 30 preeclamptic women with >30 weeks gestation and aged 18-35 years, was conducted at the Korle-Bu Teaching Hospital. Magnesium and calcium were determined using a flame atomic absorption spectrometer. Results: Mean serum magnesium and total calcium levels in preeclamptic women were 0.70±0.15 and 2.13±0.30 mmol/L, respectively. Mean serum magnesium and total calcium levels in normal pregnant women were 0.76±0.14 and 2.13±0.35 mmol/L, respectively. There was a statistically nonsignificant difference in serum magnesium and total calcium in preeclamptic women compared to normal pregnant women, with p-values of 0.092 and 0.972, respectively. Conclusion: Serum magnesium and total calcium, therefore, seem not to differ in preeclamptic women compared to normal pregnant women in Ghana.

A comparative cross-sectional study was undertaken from March to June 2016 at the Korle-Bu Teaching Hospital, Ghana. The Korle-Bu Teaching Hospital is the largest tertiary referral hospital in Ghana with 17 clinical and diagnostic departments and a total bed capacity of 2,000, out of which 350 are in the Department of Gynaecology and Obstetrics. The hospital has a daily outpatient attendance of ~1,500 patients, out of whom ~100 are antenatal patients. About 10,000 to 12,000 deliveries are conducted per year at the hospital. All normal pregnant and preeclamptic women with gestations >30 weeks and aged between 18 and 35 years inclusive, visiting the antenatal clinic at the Department of Obstetrics and Gynaecology, constituted the target population, except pregnant women with renal disorders, chronic hypertension, gestational or preexisting diabetes mellitus, and those on magnesium and/or calcium therapy. Preeclampsia was diagnosed using a systolic blood pressure ≥140 mmHg and a diastolic blood pressure ≥90 mmHg plus a random urine sample proteinuria ≥1+ on dipstick.31 The sample size was determined based on a formula by Charan and Biswas32 considering a mean serum magnesium level of 0.58 mmol/L in preeclamptic women compared to 0.73 mmol/L in normal pregnant women33 at a power of 80% and a 5% significance level. Sixty pregnant women comprising 30 normal pregnant and 30 preeclamptic women with >30 weeks of gestation and between the ages of 18 and 35 years inclusive, who met the inclusion criteria were recruited consecutively and included in the study after obtaining written informed consent. After obtaining an informed consent, participants’ demographic characteristics (age, weight and height) were recorded on a structured data collection sheet. The blood pressure of the participants was measured using a mercury sphygmomanometer, twice in each participant 20 minutes apart and averaged, noting the systolic and diastolic blood pressures, from which the mean arterial pressure was calculated using the following formula: where Pulse pressure = systolic blood pressure – diastolic blood pressure Using a 5 mL syringe on a 19G hypodermic needle, 4 mL of venous blood was obtained from participants’ cubital vein under aseptic conditions. For most serum ions, samples are to be separated within 2 hours as recommended by the Clinical and Laboratory Standards Institute.34 Blood samples drawn were immediately placed in a plain test tube and sent to the laboratory for analysis. At the laboratory, the blood samples were centrifuged at 4,000 rpm for ~10 minutes to obtain the serum within 2 hours of sample collection, and subsequently stored at –20°C prior to analysis within 24 hours of sample collection. Serum magnesium and total serum calcium were determined using an atomic absorption spectrometer in an acetylene–air flame (Variant 240FS; Varian Australia Pty Ltd, VIC, Australia) with reference ranges of 0.74–1.03 mmol/L and 2.12–2.62 mmol/L, respectively. Data obtained were stored in Microsoft® Access database 2010 and analyzed with SPSS® software version 20. The age, parity, body mass index (BMI), systolic blood pressure, diastolic blood pressure and mean arterial pressure of the participants are presented as mean values ± SDs. The mean serum magnesium and total calcium levels of normal pregnant women and preeclamptic women were compared using an independent t-test and are presented in a bar chart. Pearson correlation coefficient was used to determine the association between mean arterial pressure and serum calcium and magnesium levels. A p-value <0.05 was considered statistically significant. The Ethical and Protocol Review Committee of the University of Ghana School of Medicine and Dentistry, which is affiliated to the Korle-Bu Teaching Hospital approved the study (protocol identification number: CHS-Et/M.4-P4.5/2015-2016).

N/A

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Telemedicine: Implementing telemedicine services could allow pregnant women in remote areas to access prenatal care and consultations with healthcare professionals without having to travel long distances to a hospital or clinic.

2. Mobile health (mHealth) applications: Developing mobile applications that provide educational resources, appointment reminders, and personalized health information could empower pregnant women to take an active role in their own healthcare and improve their access to important maternal health information.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, education, and support to pregnant women in underserved areas could help bridge the gap in access to maternal health services.

4. Mobile clinics: Establishing mobile clinics that travel to rural and underserved areas to provide prenatal care, screenings, and vaccinations could ensure that pregnant women who lack transportation or live far from healthcare facilities can still receive essential maternal health services.

5. Public-private partnerships: Collaborating with private healthcare providers and organizations to expand access to maternal health services in underserved areas could help increase the availability of quality care and reduce maternal mortality rates.

6. Health financing schemes: Implementing innovative health financing schemes, such as microinsurance or conditional cash transfer programs, could help alleviate financial barriers to accessing maternal health services for low-income women.

7. Maternal health awareness campaigns: Conducting targeted awareness campaigns to educate communities about the importance of prenatal care, early detection of complications, and the availability of maternal health services could help increase demand and utilization of these services.

It’s important to note that these recommendations are general and may need to be tailored to the specific context and needs of the population in Ghana.
AI Innovations Description
Based on the provided information, the study conducted at the Korle-Bu Teaching Hospital in Ghana aimed to compare serum magnesium and total calcium levels in preeclamptic women and normal pregnant women. The study found that there was a statistically nonsignificant difference in serum magnesium and total calcium levels between the two groups.

To develop this study into an innovation to improve access to maternal health, the following recommendations can be considered:

1. Further research: Conduct additional studies to explore the potential role of serum magnesium and calcium levels in the development and management of preeclampsia. This can help improve understanding of the pathophysiology of preeclampsia and potentially lead to the development of new diagnostic tools or treatment strategies.

2. Training and education: Provide training and education to healthcare professionals, particularly those working in maternal health, about the importance of monitoring serum magnesium and calcium levels in pregnant women. This can help improve the identification and management of preeclampsia, ultimately reducing maternal mortality rates.

3. Guidelines and protocols: Develop evidence-based guidelines and protocols for the monitoring and management of preeclampsia, taking into consideration the potential role of serum magnesium and calcium levels. These guidelines can be implemented in healthcare facilities to ensure standardized and effective care for pregnant women at risk of or diagnosed with preeclampsia.

4. Access to healthcare: Improve access to healthcare services for pregnant women, especially in developing countries where maternal mortality rates are higher. This can be achieved by increasing the number of healthcare facilities, improving transportation infrastructure, and implementing community-based healthcare programs.

5. Collaboration and partnerships: Foster collaboration and partnerships between healthcare providers, researchers, policymakers, and community organizations to address the challenges associated with maternal health. By working together, innovative solutions can be developed and implemented to improve access to maternal health services and reduce maternal mortality rates.

It is important to note that these recommendations are based on the provided study and may need to be further evaluated and tailored to specific contexts and healthcare systems.
AI Innovations Methodology
To improve access to maternal health, here are some potential recommendations:

1. Telemedicine: Implementing telemedicine programs can provide remote access to healthcare professionals for prenatal care, monitoring, and consultations. This can be especially beneficial for women in rural or underserved areas who may have limited access to healthcare facilities.

2. Mobile health (mHealth) applications: Developing mobile applications that provide information on prenatal care, nutrition, and maternal health can empower women to take control of their own health. These apps can also send reminders for appointments and medication, improving adherence to prenatal care.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, education, and support to pregnant women in their communities can help bridge the gap in access to healthcare services, particularly in remote or marginalized areas.

4. Transportation services: Establishing transportation services specifically for pregnant women can help overcome barriers related to distance and transportation costs. This can ensure that women can easily access prenatal care and emergency obstetric services.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific population that will benefit from the recommendations, such as pregnant women in a particular region or demographic group.

2. Collect baseline data: Gather information on the current access to maternal health services, including the number of women receiving prenatal care, distance to healthcare facilities, and any existing barriers to access.

3. Implement the recommendations: Introduce the recommended innovations, such as telemedicine programs, mHealth applications, community health worker programs, or transportation services.

4. Monitor and evaluate: Track the implementation of the recommendations and collect data on key indicators, such as the number of women utilizing the innovations, changes in prenatal care attendance rates, and feedback from users.

5. Analyze the data: Use statistical analysis to assess the impact of the recommendations on improving access to maternal health. This may involve comparing pre- and post-implementation data, conducting surveys or interviews with users, and examining any changes in health outcomes.

6. Adjust and refine: Based on the evaluation results, make any necessary adjustments or refinements to the recommendations to further improve access to maternal health.

By following this methodology, it is possible to simulate and measure the impact of innovations on improving access to maternal health, allowing for evidence-based decision-making and continuous improvement.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email